Rethymic Interactions
There are 249 drugs known to interact with Rethymic (allogeneic processed thymus tissue), along with 1 disease interaction. Of the total drug interactions, 249 are major.
- View Rethymic disease interactions (1)
Medications known to interact with Rethymic
Note: Showing generic names only.
A
- abatacept
- abemaciclib
- abrocitinib
- acalabrutinib
- adalimumab
- adenovirus vaccine
- alefacept
- alemtuzumab
- anakinra
- anifrolumab
- anthrax vaccine adsorbed
- anti-thymocyte globulin (rabbit)
- apremilast
- asciminib
- auranofin
- avacopan
- axicabtagene ciloleucel
- azathioprine
B
- baricitinib
- basiliximab
- bcg
- bcg vaccine
- belatacept
- belimumab
- belinostat
- belumosudil
- benralizumab
- betamethasone
- bimekizumab
- blinatumomab
- brentuximab
- brexucabtagene autoleucel
- brodalumab
- budesonide
C
- canakinumab
- carfilzomib
- certolizumab
- chikungunya vaccine, live (cvx 317)
- cholera vaccine
- cholera vaccine, live
- ciltacabtagene autoleucel
- cladribine
- cortisone
- COVID-19 mRNA (Moderna) vaccine
- COVID-19 mRNA (Pfizer) vaccine
- crovalimab
- cyclophosphamide
- cyclosporine
D
- daclizumab
- danicopan
- daratumumab
- dasatinib
- deflazacort
- dengue vaccine
- denosumab
- deucravacitinib
- dexamethasone
- dimethyl fumarate
- dinutuximab
- diroximel fumarate
- dupilumab
- duvelisib
E
- eculizumab
- efalizumab
- efgartigimod alfa
- eflornithine
- elotuzumab
- elranatamab
- emapalumab
- epcoritamab
- etanercept
- etrasimod
- everolimus
F
G
H
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-t) vaccine
- hepatitis a adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b pediatric vaccine
- human papillomavirus vaccine
- hydrocortisone
I
- ibritumomab
- ibrutinib
- idecabtagene vicleucel
- idelalisib
- imetelstat
- inebilizumab
- infliximab
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
- influenza virus vaccine, live
- inotuzumab ozogamicin
- iptacopan
- isatuximab
- ixekizumab
J
L
- leflunomide
- lenalidomide
- lifileucel
- lisocabtagene maraleucel
- loncastuximab tesirine
- lurbinectedin
- lymphocyte immune globulin, anti-thy (equine)
M
- measles virus vaccine
- meningococcal conjugate vaccine
- meningococcal group acwy conjugate-group b vaccine (cvx 316)
- meningococcal group B vaccine
- meningococcal polysaccharide vaccine
- mepolizumab
- mercaptopurine
- methotrexate
- methylprednisolone
- mirikizumab
- mixed respiratory vaccine
- mogamulizumab
- momelotinib
- monomethyl fumarate
- mosunetuzumab
- mumps virus vaccine
- muromonab-cd3
- mycophenolate mofetil
- mycophenolic acid
N
O
P
- pacritinib
- palbociclib
- panobinostat
- pazopanib
- pegcetacoplan
- pertussis, acellular
- pirtobrutinib
- plague vaccine
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 21-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- polatuzumab vedotin
- poliovirus vaccine, inactivated
- poliovirus vaccine, live, trivalent
- pomalidomide
- ponatinib
- ponesimod
- pozelimab
- prednisolone
- prednisone
R
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- ravulizumab
- reslizumab
- rilonacept
- risankizumab
- ritlecitinib
- rituximab
- roflumilast
- romidepsin
- rotavirus vaccine
- rozanolixizumab
- rsv vaccine pref3, recombinant
- rsv vaccine, mrna
- rsv vaccine, pref a-pref b, recombinant
- rubella virus vaccine
- ruxolitinib
S
- sacituzumab govitecan
- sarilumab
- sars-cov-2 (covid-19) ad26 vaccine, recombinant
- sars-cov-2 (covid-19) chadox1 vaccine, recombinant
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)
- sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
- sars-cov-2 (covid-19) rs-nanoparticle vaccine, recombinant
- sars-cov-2 mrna (tozinameran 5y-11y) vaccine
- sars-cov-2 mrna (tozinameran 6m-4y) vaccine
- sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
- sars-cov-2 mrna (tozinameran) vaccine
- sars-cov-2 mrna-1273 (6m-5y) vaccine
- sars-cov-2 mrna-1273 (6y-11y) vaccine
- sars-cov-2 mrna-1273 (booster only) vaccine
- sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313)
- sars-cov-2 pres dtm (booster only) vaccine, recombinant
- satralizumab
- secukinumab
- selinexor
- siltuximab
- siponimod
- sipuleucel-T
- sirolimus
- sirolimus protein-bound
- smallpox and mpox vaccine
- smallpox vaccine
- spesolimab
- staphage lysate (spl)
- sutimlimab
T
- tacrolimus
- tafasitamab
- talimogene laherparepvec
- talquetamab
- tarlatamab
- tazemetostat
- teclistamab
- temsirolimus
- teriflunomide
- tetanus toxoid
- thalidomide
- tick-borne encephalitis (inactivated) pediatric vaccine
- tick-borne encephalitis (inactivated) vaccine
- tildrakizumab
- tisagenlecleucel
- tocilizumab
- tofacitinib
- tralokinumab
- triamcinolone
- typhoid vaccine, inactivated
- typhoid vaccine, live
U
V
Y
Z
Rethymic disease interactions
There is 1 disease interaction with Rethymic (allogeneic processed thymus tissue) which include:
More about Rethymic (allogeneic processed thymus tissue)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: other immunostimulants
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.